Literature DB >> 22459691

Thirty years of research on infection and prostate cancer: no conclusive evidence for a link. A systematic review.

Jan Hrbacek1, Michael Urban, Eva Hamsikova, Ruth Tachezy, Jiri Heracek.   

Abstract

BACKGROUND: The potential role of genitourinary infection in the etiology of prostate cancer (CaP) has been extensively investigated for 30 years. Two basic approaches have been used: tissue-based methods (polymerase chain reaction, immunohistochemistry, and in situ hybridization) and serologic assays (enzyme-linked immunosorbent assay, immunofluorescence, etc.). The objective of this review was to answer the question of whether infection of the male genitourinary tract may have a role in the etiology of CaP.
MATERIALS AND METHODS: We have carried out a systematic review of the evidence that was published in the MEDLINE/PubMed database until December 2011. The search terms included "prostate cancer," "infection," and the explicit names of the various infectious agents. Additional studies were identified using a reference search. A total of 74 papers were included in the review, which cover the following infectious agents: human papillomavirus, cytomegalovirus, herpes simplex virus, Epstein-Barr virus, human herpesvirus, BK virus, JC virus, chlamydia, mycoplasma, ureaplasma, trichomonas, neisseria, treponema, Propionibacterium acnes, xenotropic murine leukemia virus-related virus and Candida albicans.
RESULTS: Despite the variable study designs and methodological approaches that were used, most of the pathogens that were studied were unlikely to be directly involved in prostate carcinogenesis.
CONCLUSIONS: The role of infection in the etiology of CaP has yet to be determined despite 30 years of research efforts. A discovery of an infectious agent that is associated with CaP would be of great medical importance; however, such a link would have to be firmly established before impacting on patient care.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Etiology; Infection; Prostate cancer; Serology; Sexually transmitted diseases

Mesh:

Year:  2012        PMID: 22459691     DOI: 10.1016/j.urolonc.2012.01.013

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  20 in total

Review 1.  The inflammatory microenvironment and microbiome in prostate cancer development.

Authors:  Karen S Sfanos; Srinivasan Yegnasubramanian; William G Nelson; Angelo M De Marzo
Journal:  Nat Rev Urol       Date:  2017-10-31       Impact factor: 14.432

Review 2.  A critical review of the epidemiology of Agent Orange/TCDD and prostate cancer.

Authors:  Ellen T Chang; Paolo Boffetta; Hans-Olov Adami; Philip Cole; Jack S Mandel
Journal:  Eur J Epidemiol       Date:  2014-07-27       Impact factor: 8.082

3.  Association between human papillomavirus and prostate cancer: A meta-analysis.

Authors:  Binbin Yin; Weiwei Liu; Pan Yu; Chunhua Liu; Yue Chen; Xiuzhi Duan; Zhaoping Liao; Yuhua Chen; Xuchu Wang; Xiaoyan Pan; Zhihua Tao
Journal:  Oncol Lett       Date:  2017-06-09       Impact factor: 2.967

4.  Infections and inflammation in prostate cancer.

Authors:  Karen S Sfanos; William B Isaacs; Angelo M De Marzo
Journal:  Am J Clin Exp Urol       Date:  2013-12-25

5.  Human herpesvirus 8 infection is associated with prostate cancer among IFNL4-ΔG carriers.

Authors:  Frank J Jenkins; Tsion Z Minas; Wei Tang; Tiffany H Dorsey; Stefan Ambs
Journal:  Prostate Cancer Prostatic Dis       Date:  2022-04-25       Impact factor: 5.554

Review 6.  MSMB variation and prostate cancer risk: clues towards a possible fungal etiology.

Authors:  Siobhan Sutcliffe; Angelo M De Marzo; Karen S Sfanos; Martin Laurence
Journal:  Prostate       Date:  2014-01-24       Impact factor: 4.104

7.  Propionibacterium acnes populations involved in deep pathological samples and their dynamics along the cardiac surgical pathway.

Authors:  S Romano-Bertrand; M Beretta; H Jean-Pierre; J-M Frapier; B Calvet; S Parer; E Jumas-Bilak
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-08-30       Impact factor: 3.267

8.  Antibody response to BK polyomavirus as a prognostic biomarker and potential therapeutic target in prostate cancer.

Authors:  Xavier Etienne Keller; Piotr Kardas; Claudio Acevedo; Giovanni Sais; Cédric Poyet; Irina Banzola; Ashkan Mortezavi; Burkhardt Seifert; Tullio Sulser; Hans H Hirsch; Maurizio Provenzano
Journal:  Oncotarget       Date:  2015-03-20

9.  Consumption of fish products across the lifespan and prostate cancer risk.

Authors:  Johanna E Torfadottir; Unnur A Valdimarsdottir; Lorelei A Mucci; Julie L Kasperzyk; Katja Fall; Laufey Tryggvadottir; Thor Aspelund; Orn Olafsson; Tamara B Harris; Eirikur Jonsson; Hrafn Tulinius; Vilmundur Gudnason; Hans-Olov Adami; Meir Stampfer; Laufey Steingrimsdottir
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

10.  Viral infections in prostate carcinomas in Chilean patients.

Authors:  Hector Rodríguez; Jorge Levican; Juan P Muñoz; Diego Carrillo; Mónica L Acevedo; Aldo Gaggero; Oscar León; Tarik Gheit; Omar Espinoza-Navarro; Jorge Castillo; Iván Gallegos; Massimo Tommasino; Francisco Aguayo
Journal:  Infect Agent Cancer       Date:  2015-09-01       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.